Inherent Biosciences Launches Path Fertility – Epigenetic Sperm Quality Test (SpermQT)
SpermQT analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis. […]
About:Press Release
Posts by Press Release :
Utah Business 40 Under 40
Utah Business is proud to present its annual 40 Under 40 event that will be held in February 2022. […]
DiscGenics Honored by Goldman Sachs for Entrepreneurship
BioUtah member Discgenics Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit. […]
BioUtah Kicks-Off the 2021 Virtual BioHive Summit with Dr. Dean Li, President, Merck Research Laboratories
The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry. […]
New WTC Utah Grants for Doing Business in the Middle East
Join WTC Utah in Dubai, UAE for the largest U.S. government-led trade mission and business development forum. […]
Certus Critical Care Awarded Two Department of Defense Grants for Development of Endovascular Device
Grants Totaling Over $3M Earmarked for Life Saving Medical Technology to Combat Massive Blood Loss […]
MPF II NEXT Makes its Debut Investment in iVeena Delivery Systems
A clinical stage ophthalmology company, iVeena is developing disease-modifying therapeutics for a rare corneal disorder and an increasingly common form of nearsightedness […]
Stryker: Patient impact: our inspiration
Stryker CEO, Kevin Lobo, recently shared his thoughts about his work at Stryker and what it means to help make a difference for patients […]
BioHive Names Katelin Roberts Executive Director
BioHive, Utah’s collective of life sciences and healthcare innovation companies, today announced that Katelin Roberts will serve as the full time Executive Director, effective immediately. […]
Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Recursion announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP). […]
NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. […]
SINTX ARMOR SHIPS FIRST ORDER AND PREPARES FOR MOVE TO UTAH
SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today that its newly created and wholly-owned subsidiary, SINTX Armor, will be located in Salt Lake City, Utah and that it has signed a 10-year lease on a facility to house development and manufacturing activities for SINTX Armor. […]